Brief: Immunovia Q4 Revenue SEK 455 Thousand
25/02/2025 07:30
Feb 25 (Reuters) - Immunovia Q4 adjusted free cash flow SEK -28.3 million. * Q4 adjusted EPS SEK 0.02 * Q4 net income SEK 3.1 million
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study